{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T22:30:18Z","timestamp":1769812218965,"version":"3.49.0"},"reference-count":30,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T00:00:00Z","timestamp":1343260800000},"content-version":"vor","delay-in-days":8030,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[1990,8]]},"abstract":"<jats:p>The metabolic activation of the arylbiguanide antimalarials proguanil (PG) and chlorproguanil (CPG) has been investigated in liver microsomes from three human livers. All three microsomal preparations activated the biguanides. The kinetic parameters for PG metabolism to cycloguanil (CG) were Km 21.8, 29.6 and 26.4 microM and Vmax 1.5, 5.9, and 8.2 pmol min\u20101 mg\u20101. The values for CPG conversion to chlorcycloguanil (CCG) were Km 12.9, 19.7 and 26.1 microM and Vmax 5.7, 4.8 and 3.6 pmol min\u20101 mg\u20101. The metabolic activation of both biguanides was competitively inhibited by the anticonvulsant mephenytoin. Sparteine and tolbutamide had no effect on biguanide metabolism. These data suggest an involvement of the mephenytoin hydroxylase enzyme, which exhibits a genetic polymorphism in man, in the metabolic activation of the biguanide antimalarials.<\/jats:p>","DOI":"10.1111\/j.1365-2125.1990.tb03777.x","type":"journal-article","created":{"date-parts":[[2012,7,27]],"date-time":"2012-07-27T00:34:00Z","timestamp":1343349240000},"page":"287-291","source":"Crossref","is-referenced-by-count":53,"title":["In vitro metabolism of the biguanide antimalarials in human liver microsomes: evidence for a role of the mephenytoin hydroxylase (P450 MP) enzyme."],"prefix":"10.1111","volume":"30","author":[{"given":"NA","family":"Helsby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SA","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RE","family":"Howells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AM","family":"Breckenridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,26]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.73.7.2501"},{"key":"e_1_2_1_3_1","first-page":"3832B","article-title":"Metabolism of chlorguanide, a unique mixed function oxidase substrate","volume":"33","author":"Armstrong V. L.","year":"1973","journal-title":"Diss. Abstr."},{"key":"e_1_2_1_4_1","first-page":"90","article-title":"Cyclisation and N\u2010dealkylation of chlorguanide by rabbit and rat hepatic microsomes","volume":"29","author":"Armstrong V. L.","year":"1974","journal-title":"Toxicol. appl. Pharmac."},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0026-895X(25)14267-3","article-title":"Substrate specificity of the form of cytochrome P450 catalysing the 4\u2010hydroxylation of debrisoquine in man","volume":"23","author":"Boobis A. R.","year":"1983","journal-title":"Mol. Pharmac."},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/1681080a0"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj0550170"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.3109\/03602537908993891"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00562059"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1986.113"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1985.tb02800.x"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)83616-6"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00541938"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja01318a036"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)91430-1"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1985.213"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00399a065"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1985.194"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)92711-2"},{"key":"e_1_2_1_21_1","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/S0021-9258(20)82244-3","article-title":"The carbon\u2010monoxide binding pigment of liver microsomes","volume":"239","author":"Omura T.","year":"1964","journal-title":"J. biol. Chem."},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1987.tb03074.x"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.28.1.41"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(87)80526-1"},{"key":"e_1_2_1_25_1","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/cpt1977225part2659","article-title":"Genetic and environmental factors affecting drug disposition in man","volume":"22","author":"Vesell E. S.","year":"1973","journal-title":"Clin. Pharmac. Ther."},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1989.11"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1989.tb03440.x"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1987.tb06263.x"},{"key":"e_1_2_1_29_1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5962\/bhl.title.7320","volume-title":"Enzyme and metabolic inhibitors","author":"Webb J. L.","year":"1963"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1984.256"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/jramc-131-03-07"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.1990.tb03777.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.1990.tb03777.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T14:50:40Z","timestamp":1743864640000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.1990.tb03777.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,8]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1990,8]]}},"alternative-id":["10.1111\/j.1365-2125.1990.tb03777.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.1990.tb03777.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,8]]}}}